Effect of Febuxostat on Blood Pressure
Public ClinicalTrials.gov record NCT01496469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effect of febuxostat, once daily (QD), compared to placebo on lowering ambulatory 24-hour mean blood pressure of participants with hypertension and hyperuricemia (not associated with gout).
Study identification
- NCT ID
- NCT01496469
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2012 (Type not available)
- Primary completion
- Aug 2014 (Actual)
- Completion
- Aug 2014 (Actual)
- Last update posted
- Aug 31, 2015
2012 – 2014
United States locations
- U.S. sites
- 45
- U.S. states
- 22
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Foley | Alabama | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Lomita | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Wildomar | California | — | — |
| Not listed | Milford | Connecticut | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Dunwoody | Georgia | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Suwanee | Georgia | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Biddeford | Maine | — | — |
| Not listed | City of Saint Peters | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Henderson | Nevada | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Glens Falls | New York | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Salisbury | North Carolina | — | — |
| Not listed | Shelby | North Carolina | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Tipton | Pennsylvania | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Port Orchard | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01496469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2015 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01496469 live on ClinicalTrials.gov.